Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice
Description
Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing.
Credit available for this activity expires: 12/5/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999024?ecd=bdc_podcast_libsyn_mscpedu
Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer?
Credit available for this activity expires: 4/23/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000702?ecd=bdc_podcast_libsyn_mscpedu
Published 04/25/24
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures:...
Published 04/25/24